- Category: HCV Treatment
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
The first U.S. hepatitis C treatment guidelines incorporating interferon-free direct-acting antiviral regimens were issued in January 2014 and periodically updated to reflect new drug approvals and emerging data from studies and real-world use. The new therapies have cure rates above 90%, but cost and other barriers have limited their use.